Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$678,884
New position
Shares Held
8,600
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in BLLN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,807,726
PutShares
22,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $60,505,057 across 14 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
86,744 | $19,672,671 | |
| 2 | DHR |
Danaher Corp /De/
|
85,126 | $16,214,799 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
21,165 | $10,611,283 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,495 | $2,366,347 | |
| 5 | A |
Agilent Technologies, Inc.
|
16,083 | $2,136,304 | |
| 6 | WAT |
Waters Corp /De/
|
5,590 | $2,096,472 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
9,518 | $1,839,067 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,151 | $1,470,413 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,807,726 | 22,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $678,884 | 8,600 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||